Firefly Neuroscience Files 8-K on Financials
Ticker: AIFF · Form: 8-K · Filed: Nov 15, 2024 · CIK: 803578
Sentiment: neutral
Topics: financial-condition, operations-update
TL;DR
Firefly Neuroscience dropped an 8-K detailing its financial condition as of Nov 14, 2024.
AI Summary
Firefly Neuroscience, Inc. filed an 8-K on November 15, 2024, reporting on its results of operations and financial condition as of November 14, 2024. The filing details financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on Firefly Neuroscience's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- FIREFLY NEUROSCIENCE, INC. (company) — Registrant
- November 14, 2024 (date) — Date of earliest event reported
- November 15, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 1100 Military Road Kenmore, NY 14217 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Firefly Neuroscience, Inc.
What is the exact name of the company filing this report?
The exact name of the company is FIREFLY NEUROSCIENCE, INC.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on November 14, 2024.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What is the address of Firefly Neuroscience, Inc.'s principal executive offices?
The address of the principal executive offices is 1100 Military Road, Kenmore, NY 14217.
Filing Stats: 551 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-11-14 17:35:23
Key Financial Figures
- $0.0001 — on which registered Common Stock , $0.0001 par value per share AIFF The Nasdaq
Filing Documents
- wavd20241112_8k.htm (8-K) — 33KB
- ex_747995.htm (EX-99.1) — 18KB
- fireflylogo.jpg (GRAPHIC) — 4KB
- 0001437749-24-035398.txt ( ) — 192KB
- wavd-20241114.xsd (EX-101.SCH) — 3KB
- wavd-20241114_def.xml (EX-101.DEF) — 11KB
- wavd-20241114_lab.xml (EX-101.LAB) — 15KB
- wavd-20241114_pre.xml (EX-101.PRE) — 11KB
- wavd20241112_8k_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On November 14, 2024, Firefly Neuroscience, Inc. issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2024, and provided a stockholder update. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, being furnished pursuant to Item 2.02, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Press Release dated November 14, 2024* 104 Cover Page Interactive Data File (formatted as Inline XBRL) * This exhibit is furnished pursuant to Item 2.02 and shall not be deemed to be "filed."
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FIREFLY NEUROSCIENCE, INC. Date: November 14, 2024 By: /s/ Jon Olsen Name: Jon Olsen Title: Chief Executive Officer